Application 050824

Type
NDA
Sponsor
CUMBERLAND PHARMS

Related Records

Application Products

ProductDrugIngredientFormStrengthReference drugReference standard
001OMEPRAZOLE AND CLARITHROMYCIN AND AMOXICILLINAMOXICILLIN; CLARITHROMYCIN; OMEPRAZOLECAPSULE, TABLET, CAPSULE, DELAYED RELEASE;ORAL500MG,N/A,N/A;N/A,500MG,N/A;N/A,N/A,20MGYesYes

NDC Listings For This Application

NDCNameNonproprietary nameLabelerMarketing categoryStatus
66220-422Omeclamox-Pakomeprazole, clarithromycin, amoxicillinCumberland Pharmaceuticals Inc.NDACurrent
66220-422Omeclamox-Pakomeprazole, clarithromycin, amoxicillinCumberland Pharmaceuticals Inc.NDACurrent
66220-422Omeclamox-Pakomeprazole, clarithromycin, amoxicillinCumberland Pharmaceuticals Inc.NDACurrent
66220-422Omeclamox-Pakomeprazole, clarithromycin, amoxicillinCumberland Pharmaceuticals Inc.NDACurrent
66220-422Omeclamox-Pakomeprazole, clarithromycin, amoxicillinCumberland Pharmaceuticals Inc.NDACurrent

Documents

DocumentSubmission typeDate
78386SUPPL 2024-05-03
78357SUPPL 2024-05-02
75127SUPPL 2023-08-18
75126SUPPL 2023-08-18
75103SUPPL 2023-08-17
75102SUPPL 2023-08-17
70485SUPPL2022-03-11
70430SUPPL2022-03-07
65426SUPPL2020-12-01
65366SUPPL2020-11-30
61623SUPPL2020-01-23
61618SUPPL2020-01-22
53933ORIG2018-05-01
52434APPL2018-02-06
45725SUPPL2016-10-31
45649SUPPL2016-10-26
39393SUPPL2015-01-09
8345SUPPL2014-12-31
24352ORIG2011-12-08
22252ORIG2011-12-08
8344ORIG2011-02-14
18301ORIG2011-02-09